In Re Investors Bancorp, Inc. Stockholder Litigation

177 A.3d 1208
CourtSupreme Court of Delaware
DecidedDecember 13, 2017
Docket169, 2017
StatusPublished
Cited by39 cases

This text of 177 A.3d 1208 (In Re Investors Bancorp, Inc. Stockholder Litigation) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Investors Bancorp, Inc. Stockholder Litigation, 177 A.3d 1208 (Del. 2017).

Opinion

SEITZ, Justice:

In this appeal we consider the limits of the stockholder ratification defense when directors make equity awards to themselves under the general parameters of an equity incentive plan. In the absence of stockholder approval, if a stockholder properly challenges equity incentive plan awards the directors grant to themselves, the directors must prove that the' awards are entirely fair to the corporation. But, when the stockholders have approved an equity incentive plan, the affirmative defense of stockholder ratification comes into play. Stated generally, stockholder ratification means a majority of fully informed, uncoerced, and disinterested stockholders approved board action, which, if chállenged, typically leads to a deferential business judgment standard of review.

For equity incentive plans in which the award terms are fixed and the directors have no discretion how they, allocate the awards, the. stockholders know exactly what they are being asked to approve. But, other plans — like the equity incentive plan in this appeal — create a pool of equity awards that the directors can later award to themselves in amounts and on terms they decide. The Court of Chancery has recognized a ratification defense for such discretionary plans as long as the plan has “meaningful limits” on the' awards directors can make to themselves. 1 If the discretionary plan does not contain meaningful limits, the awards, if challenged, are subject to an entire fairness standard of review.

Stockholder ratification serves'an important purpose — directors can take self-interested action secure in the knowledge that the stockholders have expressed their approval. But, when directors make discretionary awards to themselves, that discretion must be exercised consistent with their fiduciary duties. Human nature being what It is, 2 self-interested .discretionary acts by directors should in an appropriate case be subject to review by the Court of Chancery.

We balance the competing concerns — utility of the ratification defense and the need for judicial scrutiny of certain self-interested discretionary acts by directors — by focusing on the specificity of the acts submitted to the stockholders for approval. When the directors submit their specific compensation decisions for approval by fully informed, uncoerced, and disinterested stockholders, ratification is properly asserted as a defense in support of a motion to dismiss. The same applies for self-executing, plans, meaning plans that make awards over time based on fixed criteria, with the specific amounts and terms approved-by the stockholders. But, when stockholders have approved an equity incentive plan that gives the directors discretion to grant themselves awards within general parameters, and a. stockholder properly alleges that the directors inequitably exercised that discretion, then the ratification defense is unavailable to dismiss the suit, and the directors will be required to prove the fairness of the awards to the corporation.

•Here, the Equity Incentive Plan (“EIP”) approved by the stockholders left it to the discretion of the directors to allocate up' to 30% of all option or restricted stock shares available as awards to themselves. The plaintiffs have alleged facts leading to a pleading stage reasonable inference that the directors breached their fiduciary duties by- awarding excessive .. equity awards to themselves under the EIP. Thus, a stockholder ratification defense is not available to dismiss the case, and the directors must demonstrate the fairness of the awards to the Company. We therefore reverse the Court of Chancery’s decision dismissing the complaint and remand for further proceedings consistent with this opinion.

I.

According to the allegations of the complaint, which we must accept as’ true at this stage of -the proceedings, 3 the plaintiffs áre stockholders of Investors Ban-corp, Inc. (“Investors Bancorp” or the “Company”) and were stockholders at the time of the awards challenged in this case. The defendants fall into two groups — ten non-employee director defendants 4 and two executive director defendants. 5 Investors Bancorp, the nominal defendant, is a Delaware corporation with its principal place of business in Short Hills, New Jersey. Investors Bancorp is” a holding company for Investors Bank, a New' Jersey Chartered savings bank with corporate headquarters in Short Hills, New Jersey. The Company operates 143 banking branches in New Jersey and New York. In 2014, after a mutual-to-stock conversion, 6 Investors Bancorp conducted a second-step offering to the public, which is when the plaintiffs acquired their shares. In this second-step offering, the Company sold 219,580)695 shares and raised about $215 billion.

The board sets director compensation based on recommendations of the Compensation and Benefits Committee (“Committee”), composed of seven of the ten non-employee directors. In 2014, the non-employee directors were compensated by (i) a monthly cash retainer; (ii) cash áwards for attending board and board committee meetings; and (iii) perquisites and personal benefits. The 'Chairman of each committee received an additional annual retainer. As the Court of Chancery noted, the annual compensation for all non-employee directors ranged from $97,200 to $207,005, with $133,340 as the average amount of compensation per director:

[[Image here]]

In 2014, Cummings, the Company’s President and CEO, received ,,(i) a $1,000,000 base salary; (ii) an Annual Cash Incentive Award of up to 150% of his base salary contingent on certain performance goals; and (iii) perquisites and benefits valued at ' $278,400, which totaled $2,778,700. Cama, the Company’s COO and Senior Executive Vice President, received annual' compensation consisting of (i) a $675,000 base salary; (ii) an Annual Cash Incentive Award of up to 120% of his base salary; and (iii) perquisites and benefits valued at $180,794, which totaled $1,665,794. 7

At the end of 2014, following completion of the conversion plan, the Committee met to review 2014 director compensation and set compensation for 2015. Gregory Kesh-ishian, a compensation consultant from GK Partners, Inc., presented to the board a study of director compensation for eighteen publicly held peer companies. According to the study, these companies paid their non-employee directors an .average of $157,350 in total compensation. The Company’s $133,340 average non-employee director compensation in 2014 fell close to the study average. Following the presentation, the Committee recommended to the board that the non-employee director compensation package remain the same for 2015. The only change wás to increase the fees paid for. attending committee meetings from $1,500 to $2,500.

The Committee also reviewed the compensation package for executive officers.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Patrick Ayers v. William P. Foley
Court of Chancery of Delaware, 2026
DSM Holdco, Inc. v. Demoulas
Court of Chancery of Delaware, 2026
Roy Mitchell Edmondson v. Daniel Oakes
Court of Chancery of Delaware, 2026
Daniel S. Peña v. MacArthur Group, Inc.
Court of Chancery of Delaware, 2025
Foley v. Session Corp.
Court of Chancery of Delaware, 2025
In Re The Trade Desk, Inc. Derivative Litigation
Court of Chancery of Delaware, 2025
Richard J. Tornetta v. Elon Musk
Court of Chancery of Delaware, 2024
Stephen Gunderson v. The Trade Desk, Inc.
Court of Chancery of Delaware, 2024
Ted D. Kellner v. AIM ImmunoTech Inc.
Supreme Court of Delaware, 2024
In re Match Group, Inc. Derivative Litigation
Supreme Court of Delaware, 2024
Palkon v. Maffei
Court of Chancery of Delaware, 2024
CCSB Financial Corp. v. Deann M. Totta
Supreme Court of Delaware, 2023
New Enterprise Associates 14, L.P. v. Rich
Court of Chancery of Delaware, 2023
Griffith v. Stein
Supreme Court of Delaware, 2022
Deann M. Totta v. CCSB Financial Corp.
Court of Chancery of Delaware, 2022
Garfield v. Allen
Court of Chancery of Delaware, 2022
Robin Knight v. Alan B. Miller
Court of Chancery of Delaware, 2022

Cite This Page — Counsel Stack

Bluebook (online)
177 A.3d 1208, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-investors-bancorp-inc-stockholder-litigation-del-2017.